Compass Therapeutics News

Compass Therapeutics Analyst Ratings

BenzingaJun 3 18:58

HC Wainwright & Co. : The Compass Therapeutics (CMPX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.

Zhitong FinanceMay 16 23:50

Compass Therapeutics Analyst Ratings

BenzingaMay 16 23:46

Compass Therapeutics: A Buy Rating on Promising Pipeline and Solid Financials

TipRanksMay 16 16:06

HC Wainwright & Co. : The Compass Therapeutics (CMPX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.

Zhitong FinanceMay 14 22:50

Compass Therapeutics Analyst Ratings

BenzingaMay 14 22:48

Buy Rating Affirmed for Compass Therapeutics on Strong Financials and Promising Clinical Trials

TipRanksMay 14 21:35

Compass Therapeutics Analyst Ratings

BenzingaApr 17 00:18

HC Wainwright & Co. : The Compass Therapeutics (CMPX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.

Zhitong FinanceApr 17 00:20

Analysts Offer Insights on Healthcare Companies: SAB Biotherapeutics (SABS) and Compass Therapeutics (CMPX)

TipRanksApr 16 22:00

Buy Rating on Compass Therapeutics for Breakthrough in Resistant Tumor Treatment

TipRanksApr 10 18:27

Wedbush Reiterates Outperform on Compass Therapeutics, Maintains $8 Price Target

BenzingaMar 22 21:58

Compass Therapeutics' Strategic Advancements and Strong Financials Prompt Buy Rating

TipRanksMar 21 23:15

Compass Therapeutics Analyst Ratings

BenzingaMar 21 23:07

Optimistic Outlook: Buy Rating on Compass Therapeutics Amid Positive Clinical Development Milestones

TipRanksJan 5 22:46

Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG), 4D Molecular Therapeutics (FDMT) and Compass Therapeutics (CMPX)

TipRanksNov 14, 2023 15:20

Analysts Conflicted on These Healthcare Names: HUTCHMED (HCM), Bayer (OtherBAYRY) and Compass Therapeutics (CMPX)

TipRanksNov 9, 2023 22:22

HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target

BenzingaAug 4, 2023 01:25

Compass Therapeutics Analyst Ratings

BenzingaAug 4, 2023 01:24

Analysts Have Conflicting Sentiments on These Healthcare Companies: Compass Therapeutics (CMPX), Pacira Pharmaceuticals (PCRX) and Bluejay Diagnostics (BJDX)

TipRanksAug 3, 2023 22:30